facebook twitter linkedin

This material was prepared by a third party towards Selvita S.A. with its registered office in Kraków (hereunder: “Selvita”). Within the scope which was not authorized by Selvita’s management board, the description of factual circumstances regarding the activities of Selvita, embodied in this material presents merely opinion of the third party, in particular with respect to presented opinions, predictions, appraisals and forecasts of the financial data and future activity of Selvita and its results.

Therefore, Selvita does not warrant consistency of this material with the actual and legal situation. Neither Selvita, members of its corporate bodies, employees nor its consultants shall bear any liability for validity of opinions, predictions, appraisals, forecasts and any other date embodied in this material as well as for consequences of actions of any reader made on a basis of this material, in particular for the investment decisions or any losses resulting from use of this material.

Readers of this material shall make its own assessment, whether opinions or forecasts embodied therein are credible and adequate, in particular taking into account their investment strategy and actual and legal situation. In particular they should consult it with their independent financial and investment advisors. None of the information presented in this material shall constitute investment, legal, accounting or tax advice or a statement that any investment strategy is accurate or adequate, considering the circumstances of the reader.

Furthermore date presented in this material shall not constitute an offer to sell or purchase any financial instruments nor an invite the make such offer. It shall not be also not deemed as a recommendation for investment in any financial instrument nor an advertisement of such instruments.



DISAGREE AGREE
Place: Paris, 23rd-24th May, 2011, Paris Marriott Rive Gauche, Paris, France
 
Selvita will present during the upcoming BioEquity Europe conference in Paris.
BioEquity Europe has become a magnet for financial and pharmaceutical company dealmakers, and is the premier venue for biopharma companies looking to attract capital and expand their business development efforts. The 2011 conference is set to offer an unparalleled showcase of investment opportunities at a critical time for the life sciences.
 
We cordially invite you to our presentation at this event.
 
To arrange a meeting with Selvita's delegate at this conference, please contact: selvita@selvita.com.